Diabetes in overweight pediatric patients

2001 Tamborlane, 2005, New onset diabetes in the overweight adolescent 2001 Danne, 2001, Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type Idiabetes from the Hvidøre study group, Diabetes Care, 24, 1342, 10.2337/diacare.24.8.1342 Boland, 2001, Limitations of conventional methods of self-monitoring of blood glucose: Lessons learned from 3 days of continuous glucose sensing in pediatricpatients with type 1 diabetes, Diabetes Care, 24, 1858, 10.2337/diacare.24.11.1858 Kaufman, 2001, A pilot study of the continuous glucose monitoring system, Diabetes Care, 24, 2030, 10.2337/diacare.24.12.2030 Grey, 2001, Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes, J Adolesc Health, 28, 377, 10.1016/S1054-139X(00)00211-1 Amiel, 1986, Impaired insulin action in puberty: A contributing factor to poor glycemic control in adolescents with diabetes, N Engl J Med., 315, 215, 10.1056/NEJM198607243150402 1994, Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetesmellitus, J Pediatr., 125, 177, 10.1016/S0022-3476(94)70190-3 Craig, 2002, Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT, Med J Aust., 177, 235, 10.5694/j.1326-5377.2002.tb04754.x Bulsara, 2004, The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes, Diabetes Care, 27, 2293, 10.2337/diacare.27.10.2293 Matyka, 1999, Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes, Diabetes Care, 22, 1144, 10.2337/diacare.22.7.1144 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med., 329, 977, 10.1056/NEJM199309303291401 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of compli cations in patients withtype 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Burgert, 2004, Insulin and diabetes mellitus, 727 Lepore, 2000, Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente humaninsulin and continuous subcutaneous infusion of insulin lispro, Diabetes, 49, 2142, 10.2337/diabetes.49.12.2142 Jahle, 1999, Inadequate suspension of neutral protamine Hagedom (NPH) insulin in pens, Lancet, 354, 1604, 10.1016/S0140-6736(98)12459-5 Oiknine, 2005, A critical appraisal of the role of insulin analogues in the management of diabetes mellitus, Drugs, 65, 325, 10.2165/00003495-200565030-00003 Mohn, 1999, Lispro or regular insulin for multiple injection therapy in adolescence, Diabetes Care, 22, 27, 10.2337/diacare.22.1.27 Ahern, 2002, Insulin pump therapy in pediatrics: A therapeutic alternative to safely lower therapy HbAlc levels across all age groups, Pediatric Diabetes, 3, 10, 10.1034/j.1399-5448.2002.30103.x Maniatis, 2001, Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care, Pediatrics, 107, 351, 10.1542/peds.107.2.351 Weinzimer, 2004, Persistence of benefits of continuous subcutaneous insulin infusion (CSII) in very young children with type 1 diabetes mellitus, Pediatrics, 114, 1601, 10.1542/peds.2004-0092 Dailey, 2004, Insulin glulisine provides improved glycemic control in patients with type 2 diabetes, Diabetes Care, 27, 2363, 10.2337/diacare.27.10.2363 Yki-Järvinen, 2000, Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulincombination therapy in type 2 diabetes, Diabetes Care, 23, 1130, 10.2337/diacare.23.8.1130 Rosenstock, 2000, Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens, Diabetes Care, 23, 1137, 10.2337/diacare.23.8.1137 Ratner, 2000, Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes, Diabetes Care, 23, 639, 10.2337/diacare.23.5.639 Rossetti, 2003, Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime, Diabetes Care, 26, 1490, 10.2337/diacare.26.5.1490 Murphy, 2003, Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens, Diabetes Care, 26, 799, 10.2337/diacare.26.3.799 Doyle, 2004, A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulinglargine, Diabetes Care, 27, 1554, 10.2337/diacare.27.7.1554